Course of Vasopressin and Copeptin Plasma Concentrations in a Patient With Severe Septic Shock

From: Anaesthesia and Intensive Care | Date: August 1, 2006| Author: Jochberger, S; Luckner, G; Mayr, V D; Wenzel, V; Et al | Copyright information

SUMMARY

In this case report, the course of arginine vasopressin and copeptin, the stable C-terminal part of the arginine vasopressin precursor, is described during the period of critical illness in a septic shock patient. Arginine vasopressin and copeptin concentrations were substantially increased during the initial 36 hours of shock. Subsequently, both hormones continuously decreased, but exhibited another peak in response to stress during extubation. During restoration of cardiovasc...

Related newspaper, magazine, and journal articles from HighBeam Research

A review of septic shock
The American Surgeon ; The mortality of septic shock, both in percentage of septic shock cases and total number of septic shock cases, has been increasing over the past several decades. This is despite major advances in diagnosis and treatment. The basic cause of traumatic and septic shock has only partially been
Septic shock. (pathophysiology & treatment) (Tips from Other Journals)
American Family Physician ; Shock is a complication in almost half of all patients with sepsis. The mortality rate is between 40 and 60 percent. Rackow and Astiz review the pathophysiology and treatment of septic shock. Impairment of host defense mechanisms predisposes to the development of severe infection and septic shock.
System in shock as end nears.(News)
The Journal (Newcastle, England) ; The Pope is at risk of multi-organ failure and almost certain death after developing septic shock, a medical expert said yesterday. The Vatican said earlier that the Pontiff had suffered septic shock and heart failure after contracting a urinary tract infection. Professor Peter Weissberg, medical
Untreated infections breed danger
Chicago Sun-Times ; The importance of early treatment of common infections has been underscored by the recent death of Muppet creater Jim Henson from blood poisoning and septic shock. "Early and aggressive treatment of an infection before it releases toxins into the bloodstream is needed to prevent septic shock," said
Blind alley
Pharmaceutical Executive ; Slough, UK-Half the market value of the U.K. biotechnology company Celltech disappeared when it abandoned development of BAYX1351, the treatment for septic shock. (See Executive Profile, March 1990.) The company had partnered with Bayer to develop the product. Celltech has announced it will focus